APA

Austin L. M., Ozawa M., Kikuchi T., Walters I. B. & Krueger J. G. (19991208). The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. : The Journal of investigative dermatology.

Chicago

Austin L M, Ozawa M, Kikuchi T, Walters I B and Krueger J G. 19991208. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. : The Journal of investigative dermatology.

Harvard

Austin L. M., Ozawa M., Kikuchi T., Walters I. B. and Krueger J. G. (19991208). The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. : The Journal of investigative dermatology.

MLA

Austin L M, Ozawa M, Kikuchi T, Walters I B and Krueger J G. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. : The Journal of investigative dermatology. 19991208.